Document is current
Any future updates will be listed below
-
Authors
Wang, Qian https://orcid.org/0000-0003-4755-7001
Li, Dehai
Cao, Guangchao https://orcid.org/0000-0003-2069-3396
Shi, Qiping
Zhu, Jing
Zhang, Mingyue
Cheng, Hao
Wen, Qiong
Xu, Hao
Zhu, Leqing
Zhang, Hua
Perry, Rachel J. https://orcid.org/0000-0003-0748-8064
Spadaro, Olga
Yang, Yunfan https://orcid.org/0000-0002-5266-7208
He, Shengqi
Chen, Yong
Wang, Baocheng
Li, Guangqiang
Liu, Zonghua
Yang, Caixian
Wu, Xiaoli
Zhou, Libing
Zhou, Qinghua
Ju, Zhenyu https://orcid.org/0000-0002-9525-6521
Lu, Hongyun
Xin, Yongjie
Yang, Xiaoyong https://orcid.org/0000-0002-5315-7285
Wang, Cunchuan
Liu, Yong https://orcid.org/0000-0001-7771-4181
Shulman, Gerald I. https://orcid.org/0000-0003-1529-5668
Dixit, Vishwa Deep
Lu, Ligong https://orcid.org/0000-0002-0301-4454
Yang, Hengwen https://orcid.org/0000-0002-6418-1985
Flavell, Richard A. https://orcid.org/0000-0003-4461-0778
Yin, Zhinan https://orcid.org/0000-0001-6524-8777
- License Information
-
More Information
Article History
Received: 3 December 2018
Accepted: 13 October 2021
First Online: 24 November 2021
Competing interests
: Z.Y., Q. Wang and H.Y. have applied a patent with China National Intellectual Property Administration, with Jinan University as the applicant, Z.Y., Q. Wang and H.Y. as the inventors. The application number is 202110986914.X, and the patent covers the screening of IL-27Rα agonists for promoting UCP1 production. The other authors (D.L., G.C., Q.S., J.Z., M.Z., H.C., Q. Wen, H.X., L. Zhu, H.Z., R.J.P., O.S., Y.Y., S.H., Y.C., B.W., G.L., Z.L., C.Y., X.W., L. Zhou, Q.Z., Z.J., H.L., Y.X., X.Y., C.W., Y.L., G.I.S., V.D.D., L.L. and R.A.F.) declare no competing interests.
